NCT01427959

Completed

Tampere Traumatic Head and Brain Injury Study

Tampere University Hospital Source

Compare

Other study identifiers

Sponsor study identifier

R10027

Study Type

observational

Actual enrollment (reported)

115

Locations

1 country

Sites

1

Timeline

Study Start

November 2010

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

February 2021

Actual (reported)

Study Completion

February 2021

Actual (reported)

Brief Summary

Tampere Traumatic head and brain injury study is a prospective study aiming to explore neuroradiological, neuropsychological, neurological and biochemical aspects of mild traumatic brain injury (mtbi). The main interest is on factors that effect to the outcome after mtbi. The study is conducted in Tampere University Hospital's emergency department between the 1st of August 2010 and 31st of July 2013.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 115 participants
Study completion date: February 2021
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
November 2010
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
September 1, 2011
Actual (reported)
First Posted
September 2, 2011
Actual (reported)
Primary Completion
February 2021
Actual (reported)
Study Completion
February 2021
Actual (reported)

Last Updated: October 6, 2021
Status Verified: October 2021
Last Update Submitted: October 5, 2021

Conditions

Traumatic Brain Injury

Eligibility Criteria

Age18 Years - 60 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64)

Sampling MethodProbability Sample

Study Population

Community sample consisting of consecutive mild traumatic brain injury patients metting the enrollment criteria.

You may qualify if:

WHO's mtbi criteria
Inhabitant of Pirkanmaa hospital district
Age between 18 and 60 years

You may not qualify if:

Detrimental alcohol use

Sponsors & Collaborators

Tampere University Hospital
Otherlead

Study Sites (1)

Tampere University Hospital

Tampere, 33521, Finland

Biospecimen

Retention: SAMPLES WITH DNA

1. 10ml whole blood 2. 10ml EDTA-blood x2

MeSH Terms

Conditions

Brain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

Teemu M. Luoto, M.D.
Tampere University Hospital
PRINCIPAL INVESTIGATOR

Enrollment

115 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Medical Researcher

Study Record Dates

First Submitted

September 1, 2011

First Posted

September 2, 2011

Study Start

November 2010

Date type not reported

This date has not been verified as actual or estimated.

Deep Brain Stimulation for Traumatic Brain Injury

Not ApplicableCompleted

NCT01730443

Blood Biomarkers of Injury and Outcome in Traumatic Brain Injury

Terminated

NCT01922531

Defining Axonal Injury in Children With Mild Traumatic Brain Injury

Completed

NCT02028104

Stem Cell Therapy in Traumatic Brain Injury

Phase 1Withdrawn

NCT01215019

Osmotic Therapy for Treatment of Intracranial Hypertension for Traumatic Brain Injury

Not ApplicableWithdrawn

NCT01591759

A Pilot Trial of Citicoline in Individuals With Mild Traumatic Brain Injury (mTBI)

Phase 2Withdrawn

Drug addiction

Chronic neurological disease

Earlier brain injury

Diagnosed psychiatric disease

Hearing or sight deficiency

Native language other than finnish

Contact the study team to confirm eligibility.

Primary Completion

February 2021

Actual (reported)

Study Completion

February 2021

Actual (reported)

Last Updated

October 6, 2021

Record last verified: 2021-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01427959
Data provider: ClinicalTrials.gov
Source updated: 2021-10-06
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:23:50 UTC

Locations

FI(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations